Versant Capital Management, Inc - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
Versant Capital Management, Inc ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$505
-67.3%
7
-66.7%
0.00%
-100.0%
Q1 2023$1,545
+10.1%
210.0%0.00%0.0%
Q4 2022$1,403
-29.8%
210.0%0.00%0.0%
Q3 2022$2,000
+100.0%
21
+200.0%
0.00%
Q2 2022$1,0000.0%70.0%0.00%
Q1 2022$1,000
-50.0%
7
-36.4%
0.00%
-100.0%
Q4 2021$2,000
-86.7%
11
-89.5%
0.00%
-80.0%
Q3 2021$15,000105
+1212.5%
0.01%
Q4 2019$080.0%0.00%
Q3 2019$080.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Knott David M Jr 115,000$12,937,0004.12%
Stonepine Capital Management, LLC 73,700$8,291,0003.44%
VILLERE ST DENIS J & CO LLC 510,843$57,464,0003.41%
Chicago Capital, LLC 491,717$55,313,0002.38%
Orchard Capital Management, LLC 73,596$8,279,0002.35%
RICE HALL JAMES & ASSOCIATES, LLC 344,969$38,806,0001.55%
Smith, Graham & Co., Investment Advisors, LP 86,834$9,768,0001.02%
WOODSTOCK CORP 64,050$7,205,0000.84%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 37,246$4,190,0000.74%
Stephens Investment Management Group LLC 417,670$46,984,0000.69%
View complete list of LIGAND PHARMACEUTICALS INC shareholders